Beginner's Mind

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

April 01, 2020 Season 1 Episode 9
Beginner's Mind
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed
Beginner's Mind +
Help us continue making great content for listeners everywhere.
Starting at $3/month
Support
Show Notes Chapter Markers

These days there is a lot of discussion about the development of diagnostics, therapeutics, and vaccines against the Coronavirus and its disease COVID 19. Viruses are one threat to the health of human beings, and bacteria are another one. Traditionally, bacterial infections are treated with antibiotics, and recently, some bacteria have developed antibiotic resistance.

The WHO describes that Antibiotic resistance is one of the biggest threats to global health, food security, and development today. (https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance)

Phagomed (https://www.phagomed.com/) is developing a novel approach to treat bacterial infections without antibiotics. How that works, the challenges a company has to face while developing novel drugs, and why not all viruses are evil, you will hear in this episode.

Timestamps:
(00:00) Opening
(02:26) Intro Alexander Belcredi
(03:30) Foundation of Phagomed
(06:45) Phages – An Alternative to Antibiotics
(08:10) The Different Types of Viruses
(09:20) Why Are There Not Sufficient Solutions against Bacterial Infections?
(10:50) Competitive Landscape in the Anti-bacterial Industry
(12:30) Status of Clinical Development of Phage-Based Therapies in April 2020
(14:35) Are there Registered Phage-Based Therapies on the Market in 2020?
(16:30) How Capital Intensive is the Development of Phage-Based Therapies
(18:15) Funding Sources For Early-Stage Companies in Europe
(20:00) How to Prepare for Fundraising?
(23:30) When is the right time to go on the Market for Fundraising?
(25:00) What are the right expectations for fundraising processes? What is the success rate?
(30:45) What was the biggest challenge for Phagomed in Fundraising Phases?
(32:30) Is there a suitable time for Fundraising?
(35:20) How Long Does it Take from Starting a Financing Round to The Closing?
(36:55) Raising a Series A in 2020 – Resulted in an Acquisition in 2021
(37:55) Milestone Planning for a Series A Round
(39:05) European Public Funds to Leverage Private Investments
(42:25) What Advice Would you Give Your Younger Self Who Is at the Beginning of His Journey?

Shownotes @ PodcastNotes:
Link

More information:  
https://www.phagomed.com/
https://www.lifescienceget2gether.com/
https://linktr.ee/soschner

Video to the episode:

After Hours Entrepreneur: Your Guide to Profitable, 6-Figure Years
Quit your job. Make more money.

Listen on: Apple Podcasts   Spotify

The Rich Somers Report
Want to build wealth through real estate investing? Give this new podcast a listen!

Listen on: Apple Podcasts   Spotify

Support the show

Do you want to support the podcast team?

Join the LSG2G Newsletter as a paying member: Link

(Cont.) #9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed
(Cont.) #9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed